NORTHSTAR DISTRIBUTION CENTER — Ketorolac Importer Profile
Pharmaceutical Importer · #12 buyer for Ketorolac · $1.6M import value · 39 shipments · UNITED STATES · DGFT Verified
NORTHSTAR DISTRIBUTION CENTER is the #12 importer of Ketorolac from India with $1.6M in import value and 39 verified shipments. NORTHSTAR DISTRIBUTION CENTER holds a 1.7% market share in Ketorolac imports based in UNITED STATES. The company sources from 1 verified supplier across 7 formulations shipped to 1 country. Overall, NORTHSTAR DISTRIBUTION CENTER imports 4 pharmaceutical products worth $3.4M across 4 therapeutic categories.
NORTHSTAR DISTRIBUTION CENTER — Ketorolac Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ketorolac to NORTHSTAR DISTRIBUTION CENTER?
Verified from 39 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CAPLIN STERILES LIMITED | $1.6M | 39 | 100.0% |
NORTHSTAR DISTRIBUTION CENTER sources Ketorolac from 1 verified Indian supplier based on 39 customs records. The primary supplier is CAPLIN STERILES LIMITED accounting for 100.0% of imports.
How Does NORTHSTAR DISTRIBUTION CENTER Compare to Nearest Ketorolac Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | BAXTER HEALTHCARE CORPORATION | UNITED STATES | $6.0M | 119 | $50.0K |
| 3 | AO RANBAXY | RUSSIA | $2.8M | 56 | $50.0K |
| 12 | NORTHSTAR DISTRIBUTION CENTER ★ | UNITED STATES | $1.9M | 39 | $50.0K |
| 13 | JUNO PHARMACEUTICALS CORP | CANADA | $1.7M | 36 | $47.3K |
| 2 | AO "RANBAXY" | RUSSIA | $1.7M | 34 | $50.0K |
NORTHSTAR DISTRIBUTION CENTER ranks #12 among 638 Ketorolac importers from India. Average shipment value of $50.0K compared to the market average of $57.3K. The closest competitors by value are BAXTER HEALTHCARE CORPORATION and AO RANBAXY.
Where Does NORTHSTAR DISTRIBUTION CENTER Import Ketorolac To?
Destination countries from 39 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.6M | 39 | 100.0% |
NORTHSTAR DISTRIBUTION CENTER imports Ketorolac to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.6M.
What Ketorolac Formulations Does NORTHSTAR DISTRIBUTION CENTER Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL FORMULATIONS- KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML-1ML | $390.3K | 8 |
| PHARMACEUTICAL FORMULATIONS- KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML-1MLVLS | $326.4K | 9 |
| PHARMACEUTICAL FORMULATIONS- KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML-1ML | $220.5K | 6 |
| PHARMACEUTICAL FORMULATIONS- KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML-1ML VIAL | $219.1K | 6 |
| KETOROLAC TROMETHAMINE INJECTION USP 60MG/2ML (30MG/ML) | $206.6K | 5 |
| PHARMACEUTICAL FORMULATIONS- KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML-1MLVIAL | $109.9K | 3 |
| PHARMACEUTICAL FORMULATIONS- KETOROLAC TROMETHAMINE INJECTION USP 15MG/ML-1ML | $100.0K | 2 |
NORTHSTAR DISTRIBUTION CENTER imports 7 distinct Ketorolac formulations from India. The top formulation is PHARMACEUTICAL FORMULATIONS- KETOROLAC TROMETHAMINE INJECTIO with 8 shipments worth $390.3K.
Regulatory Requirements: Importing Ketorolac into United States
What NORTHSTAR DISTRIBUTION CENTER and other importers must comply with to import Ketorolac from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Ketorolac
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ketorolac from India and How Much Does NORTHSTAR DISTRIBUTION CENTER Import?
India exported $36.6M worth of Ketorolac through 2,961 shipments from 351 suppliers to 124 countries, serving 638 buyers globally. NORTHSTAR DISTRIBUTION CENTER imports $1.6M of this total, accounting for 1.7% of India's Ketorolac exports with 39 shipments from UNITED STATES. This is verified from 39 customs shipment records covering 7 distinct formulations.
What Is the Average Order Value for NORTHSTAR DISTRIBUTION CENTER's Ketorolac Imports?
NORTHSTAR DISTRIBUTION CENTER's average Ketorolac order value is $40.3K per consignment, based on 39 shipments totaling $1.6M. NORTHSTAR DISTRIBUTION CENTER is based in UNITED STATES and ranks #12 among all Ketorolac importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ketorolac to NORTHSTAR DISTRIBUTION CENTER?
NORTHSTAR DISTRIBUTION CENTER sources Ketorolac from 1 verified Indian supplier: CAPLIN STERILES LIMITED ($1.6M, 100.0%). This is based on 39 customs records.
How Does NORTHSTAR DISTRIBUTION CENTER Compare to Other Ketorolac Importers?
NORTHSTAR DISTRIBUTION CENTER ranks #12 among 638 Ketorolac importers from India with a 1.7% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($12.4M), BAXTER HEALTHCARE CORPORATION ($6.0M), AO RANBAXY ($2.8M). NORTHSTAR DISTRIBUTION CENTER processed 39 shipments from UNITED STATES.
About NORTHSTAR DISTRIBUTION CENTER
NORTHSTAR DISTRIBUTION CENTER imports 4 products worth $3.4M. Beyond Ketorolac, top products include Furosemide, Mesalamine, Digoxin. View the complete NORTHSTAR DISTRIBUTION CENTER profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ketorolac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ketorolac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NORTHSTAR DISTRIBUTION CENTER matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NORTHSTAR DISTRIBUTION CENTER's capped import value divided by total capped export value for Ketorolac across all Indian exporters.
- 5.Verified Records: This page is backed by 39 individual customs records matching NORTHSTAR DISTRIBUTION CENTER importing Ketorolac, covering 7 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 124+ countries, 638+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ketorolac Import Data for NORTHSTAR DISTRIBUTION CENTER
Access order-level details, pricing data, supplier connections, and competitive analysis for NORTHSTAR DISTRIBUTION CENTER's Ketorolac imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NORTHSTAR DISTRIBUTION CENTER
Full Company Profile →
4 products · $3.4M total trade · 4 categories
NORTHSTAR DISTRIBUTION CENTER × Ketorolac
Verified from customs records
Company Overview
Top Products by NORTHSTAR DISTRIBUTION CENTER
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NORTHSTAR DISTRIBUTION CENTER.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ketorolac. For current order-level data, contact TransData Nexus.